Libtayo gained FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, promising improved ...

Although neuroendocrine tumors of the digestive system have been studied, far less is known about those that develop in the ...

Emergency Medicaid spending represented only 0.4% of total Medicaid expenditures in 2022, rising to 0.9% in states with higher populations of undocumented immigrants.

Back surgeries to address age-related pain in older adults aren’t just risky, they're expensive too, according to a recent study from the Lown Institute.

Providing support and care for adults with schizophrenia can mean a significant personal and financial burden for family members.

The PIVOT-006 trial is part of a larger national effort to evaluate cretostimogene’s safety and effectiveness in bladder ...

Jascayd targets the enzyme PDE4B, which plays a role in the inflammatory process. The new therapy is able to affect both fibrosis and the immune system. It will be available in the next few weeks.

Panelists discuss how bimekizumab represents a valuable addition to the psoriatic arthritis treatment armamentarium, given its novel dual mechanism, ability to address multiple disease domains and ...

An expert discusses the growing burden of atherosclerotic cardiovascular disease (ASCVD) in the U.S., emphasizing the importance of prevention through lifestyle modification and risk factor management ...

The CDC updates vaccine schedules, emphasizing personalized decision-making for COVID-19 shots and recommending standalone ...

In this interview, Steven Buslovich, M.D., CMD, MS, CMO of Senior Care at PointClickCare describes AI’s role in care ...

Medicare beneficiaries face confusion during the Annual Enrollment Period, with significant plan changes ahead for 2026.